BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36528541)

  • 21. Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint.
    Schnitzler A; Mir P; Brodsky MA; Verhagen L; Groppa S; Alvarez R; Evans A; Blazquez M; Nagel S; Pilitsis JG; Pötter-Nerger M; Tse W; Almeida L; Tomycz N; Jimenez-Shahed J; Libionka W; Carrillo F; Hartmann CJ; Groiss SJ; Glaser M; Defresne F; Karst E; Cheeran B; Vesper J;
    Neuromodulation; 2022 Aug; 25(6):817-828. PubMed ID: 34047410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.
    Okun MS; Gallo BV; Mandybur G; Jagid J; Foote KD; Revilla FJ; Alterman R; Jankovic J; Simpson R; Junn F; Verhagen L; Arle JE; Ford B; Goodman RR; Stewart RM; Horn S; Baltuch GH; Kopell BH; Marshall F; Peichel D; Pahwa R; Lyons KE; Tröster AI; Vitek JL; Tagliati M;
    Lancet Neurol; 2012 Feb; 11(2):140-9. PubMed ID: 22239915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remotely Programmed Deep Brain Stimulation of the Bilateral Subthalamic Nucleus for the Treatment of Primary Parkinson Disease: A Randomized Controlled Trial Investigating the Safety and Efficacy of a Novel Deep Brain Stimulation System.
    Li D; Zhang C; Gault J; Wang W; Liu J; Shao M; Zhao Y; Zeljic K; Gao G; Sun B
    Stereotact Funct Neurosurg; 2017; 95(3):174-182. PubMed ID: 28571034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study.
    Lizarraga KJ; Jagid JR; Luca CC
    J Neurol; 2016 Aug; 263(8):1652-6. PubMed ID: 27278062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
    Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
    Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results.
    Harries AM; Kausar J; Roberts SA; Mocroft AP; Hodson JA; Pall HS; Mitchell RD
    J Neurosurg; 2012 Jan; 116(1):107-13. PubMed ID: 21999316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Traditional Trial and Error versus Neuroanatomic 3-Dimensional Image Software-Assisted Deep Brain Stimulation Programming in Patients with Parkinson Disease.
    Pavese N; Tai YF; Yousif N; Nandi D; Bain PG
    World Neurosurg; 2020 Feb; 134():e98-e102. PubMed ID: 31568905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.
    Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST
    J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan.
    Lahtinen MJ; Haapaniemi TH; Kauppinen MT; Salokorpi N; Heikkinen ER; Katisko JP
    Acta Neurochir (Wien); 2020 May; 162(5):1067-1076. PubMed ID: 32103343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease.
    Nunta-Aree S; Sitthinamsuwan B; Boonyapisit K; Pisarnpong A
    J Med Assoc Thai; 2010 May; 93(5):529-40. PubMed ID: 20524438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia.
    Hertel F; Züchner M; Weimar I; Gemmar P; Noll B; Bettag M; Decker C
    Neurosurgery; 2006 Nov; 59(5):E1138; discussion E1138. PubMed ID: 17143204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single electrode and multiple electrode guided electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Temel Y; Wilbrink P; Duits A; Boon P; Tromp S; Ackermans L; van Kranen-Mastenbroek V; Weber W; Visser-Vandewalle V
    Neurosurgery; 2007 Nov; 61(5 Suppl 2):346-55; discussion 355-7. PubMed ID: 18091250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Intraoperative Microlesion Effect Positively Correlates With the Short-Term Clinical Effect of Deep Brain Stimulation in Parkinson's Disease.
    Lange SF; Kremer NI; van Laar T; Lange F; Steendam-Oldekamp TE; Oterdoom DLM; Absalom AR; van Dijk JMC; Drost G
    Neuromodulation; 2023 Feb; 26(2):459-465. PubMed ID: 34494335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subthalamic nucleus deep brain stimulation programming settings do not correlate with Parkinson's disease severity.
    Far R; Saez I; Sardo A; Ovruchesky E; Sperry L; Zhang L; Shahlaie K; Girgis F
    Acta Neurochir (Wien); 2022 Sep; 164(9):2271-2278. PubMed ID: 35751700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
    Tan ZG; Zhou Q; Huang T; Jiang Y
    Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach.
    Aviles-Olmos I; Kefalopoulou Z; Tripoliti E; Candelario J; Akram H; Martinez-Torres I; Jahanshahi M; Foltynie T; Hariz M; Zrinzo L; Limousin P
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1419-25. PubMed ID: 24790212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.